Chemical and biological characterization of oxo-eicosatetraenoic acids

https://doi.org/10.1016/0304-4165(94)90083-3Get rights and content

Abstract

Eicosatetraenoates (ETEs) with 5-oxo residues are known to induce neutrophil (PMN) Ca2+ transients and chemotaxis. We find that 5-oxoETE, 5-oxo-8-trans-ETE, 5-oxo-15-hydroxy-ETE, 5-hydroxy-15-oxoETE, 5,15-dioxoETE, and 5,15-dihydroxy-ETE have respective relative potencies of 10, 5, 3, 1, 0.2, 0.1, and 0.02 in: a) causing PMN to mobilize Ca2+, aggregate, and release small amounts of granula enzymes and b) promoting large degranulation and oxidative burst responses in PMN co-challenged with platelet-activating factor, tumor necrosis factor-α, or ATP. Contrastingly, 12(R)-hydroxy-ETE, 12(S)-hydroxy-ETE, and 12-oxoETE induced PMN Ca2+ transients and aggregation [respective potencies (5-Hydroxy-ETE = 1) of 0.1, 0.01, and 0.003] but did not effect degranulation, and 15-hydroxy-ETE, 15-oxoETE, and 15-oxo-11-trans-ETE were inactive in all assays. Finally, 5-oxo/hydroxy-ETEs desensitized PMN to themseves but not to 12-oxo/hydroxy-ETEs or leukotriene (LT)B4; 12-oxo/hydroxy-ETEs and LTB4 desensitized PMN to themselves and each other but not to 5-oxo/hydroxy-ETEs; 15-oxo/hydroxy-ETEs did not desensitize PMN; and a LTB4 receptor antagonist blocked responses to LTB4 and 12-oxo/hydroxy-ETEs but not to 5-oxo/hydroxy-ETEs. Thus, 5-oxo/hydroxy-ETEs act by a common, LTB4 receptor-independent mechanism that recognizes 5- but not 12- or 15-oxo/hydroxy-ETEs and prefers oxo over hydroxy residues at C5 whereas 12-oxo/hydroxy-ETEs act via a LTB4 receptor mechanism that recognizes 12- but not 5- or 15-oxo/hydroxy-ETEs and prefers hydroxy over oxo residues at C12.

References (61)

  • S.E. Dahlen et al.
  • E.J. Goetzl et al.

    Prostaglandins

    (1981)
  • J.T. O'Flaherty et al.

    Prostagland. Leuk. Med.

    (1985)
  • J.T. O'Flaherty et al.

    J. Biol. Chem.

    (1993)
  • W.S. Powell et al.

    J. Biol. Chem.

    (1992)
  • J.T. O'Flaherty et al.

    Biochem. Biophys. Res. Commun.

    (1993)
  • E. Vioque et al.

    Arch. Biochem. Biophys.

    (1962)
  • H.W. Gardner

    Free Rad. Bio. Med.

    (1989)
  • T.A. Dix et al.

    J. Biol. Chem.

    (1985)
  • B.F. de Laclos et al.

    Biochem. Biophys. Acta

    (1988)
  • S. Narumiya et al.

    J. Biol. Chem.

    (1981)
  • D. Piomelli et al.

    J. Biol. Chem.

    (1988)
  • W.C. Glasgow et al.

    J. Biol. Chem.

    (1986)
  • W.S. Powell et al.

    J. Biol. Chem.

    (1988)
  • V. Kaever et al.

    life Sciences

    (1990)
  • R.C. Murphy et al.

    J. Biol. Chem.

    (1988)
  • A.P. Agins et al.

    Biochem. Pharm.

    (1987)
  • J.M. Bergholte et al.

    Arch. Biochem. Biophys.

    (1987)
  • H.S. Hansen

    Prostaglandins

    (1976)
  • T.M. Penning et al.

    Biochem. Biophys. Res. Commun.

    (1987)
  • S.M. Earles et al.

    Biochi. Biophys. Acta

    (1991)
  • R.L. Maas et al.

    J. Biol. Chem.

    (1982)
  • H.H. Simms et al.

    Blood

    (1994)
  • J.F. Evans et al.

    Biochem. Biophys. Acta

    (1987)
  • PH. Naccache et al.

    Life Sci.

    (1988)
  • R.J. Smith et al.

    Biochem. Biophys. Res. Commun.

    (1987)
  • D.W. Goldman et al.

    J. Exp. Med.

    (1984)
  • D.W. Goldman et al.
  • J.T. O'Flaherty et al.

    J. Cell Phys.

    (1990)
  • J.T. O'Flaherty et al.

    Am. J. Pathol.

    (1981)
  • Cited by (38)

    • The eosinophil chemoattractant 5-oxo-ETE and the OXE receptor

      2013, Progress in Lipid Research
      Citation Excerpt :

      The responses of neutrophils to 5-oxo-ETE are very similar to those of eosinophils, including chemotaxis [91], calcium mobilization [91,92], actin polymerization [93,94], and CD11b expression [94]. 5-Oxo-ETE also promotes neutrophil aggregation [95], adherence, and increased surface expression of CD11c [94]. In contrast to eosinophils, unprimed neutrophils generate little [93] or no [96] superoxide in response to 5-oxo-ETE.

    • Twelve oxo-eicosatetraenoic acid induces fetal membrane release after delivery in cows

      2012, Placenta
      Citation Excerpt :

      The identified cascade of 12-oxoETE is as follows: 12-LOX basically converts Ara to 12-HPETE; however, it can produce 12-oxoETE directly [26,27]. If 12-HPETE converts to 12-HETE by reductase, it can be changed to 12-oxoETE by dehydrogenase [26]. Ara is released from the placenta membrane by phospholipase for prostaglandin synthesis at delivery, so it is expected that the same mechanism supplies Ara to fibroblasts and converts to 12-oxoETE.

    • 5-Oxo-15-HETE: Total synthesis and bioactivity

      2011, Bioorganic and Medicinal Chemistry Letters
    • 5-Oxo-ETE and the OXE receptor

      2009, Prostaglandins and Other Lipid Mediators
    View all citing articles on Scopus
    View full text